EE04296B1 - Antidepressiivse toimega vahend, mis sisaldab pramipeksooli ja sertraliini - Google Patents

Antidepressiivse toimega vahend, mis sisaldab pramipeksooli ja sertraliini

Info

Publication number
EE04296B1
EE04296B1 EEP200100014A EEP200100014A EE04296B1 EE 04296 B1 EE04296 B1 EE 04296B1 EE P200100014 A EEP200100014 A EE P200100014A EE P200100014 A EEP200100014 A EE P200100014A EE 04296 B1 EE04296 B1 EE 04296B1
Authority
EE
Estonia
Prior art keywords
sertraline
agent containing
antidepressant agent
containing pramipexole
pramipexole
Prior art date
Application number
EEP200100014A
Other languages
English (en)
Estonian (et)
Inventor
Maj Jerzy
Original Assignee
Boehringer Ingelheim Pharma Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma Kg filed Critical Boehringer Ingelheim Pharma Kg
Publication of EE200100014A publication Critical patent/EE200100014A/xx
Publication of EE04296B1 publication Critical patent/EE04296B1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EEP200100014A 1998-07-07 1999-07-02 Antidepressiivse toimega vahend, mis sisaldab pramipeksooli ja sertraliini EE04296B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19830201A DE19830201A1 (de) 1998-07-07 1998-07-07 Mittel mit antidepressiver Wirkung
PCT/EP1999/004595 WO2000002542A2 (fr) 1998-07-07 1999-07-02 Agent a effet antidepressif

Publications (2)

Publication Number Publication Date
EE200100014A EE200100014A (et) 2002-06-17
EE04296B1 true EE04296B1 (et) 2004-06-15

Family

ID=7873155

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200100014A EE04296B1 (et) 1998-07-07 1999-07-02 Antidepressiivse toimega vahend, mis sisaldab pramipeksooli ja sertraliini

Country Status (33)

Country Link
US (1) US6255329B1 (fr)
EP (1) EP1093369B1 (fr)
JP (1) JP2002520273A (fr)
KR (1) KR100557692B1 (fr)
CN (1) CN1230168C (fr)
AR (1) AR019896A1 (fr)
AT (1) ATE228365T1 (fr)
AU (1) AU762128B2 (fr)
BG (1) BG64972B1 (fr)
BR (1) BR9911768A (fr)
CA (1) CA2336833C (fr)
CZ (1) CZ294087B6 (fr)
DE (2) DE19830201A1 (fr)
DK (1) DK1093369T3 (fr)
EA (1) EA003142B1 (fr)
EE (1) EE04296B1 (fr)
ES (1) ES2183583T3 (fr)
HK (1) HK1037976A1 (fr)
HU (1) HUP0103922A3 (fr)
ID (1) ID27776A (fr)
IL (1) IL140603A0 (fr)
MY (1) MY117969A (fr)
NO (1) NO20010064L (fr)
NZ (1) NZ509729A (fr)
PL (1) PL195043B1 (fr)
PT (1) PT1093369E (fr)
RS (1) RS49795B (fr)
SK (1) SK284923B6 (fr)
TR (1) TR200100146T2 (fr)
TW (1) TW592698B (fr)
WO (1) WO2000002542A2 (fr)
YU (1) YU401A (fr)
ZA (1) ZA200100090B (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2301899C (fr) * 1998-07-27 2008-11-18 Boehringer Ingelheim Pharma Kg Agent antidepresseur
US20020165246A1 (en) * 2001-03-05 2002-11-07 Andrew Holman Administration of sleep restorative agents
DE10138275A1 (de) * 2001-08-10 2003-02-27 Boehringer Ingelheim Pharma Verbindungen zur Beseitigung der Anhedonie
KR20040066890A (ko) * 2001-12-11 2004-07-27 유니버시티 오브 버지니아 페이턴트 파운데이션 근위축성 측삭 경화증 치료를 위한 프라미펙솔의 용도
US20060281797A1 (en) * 2001-12-11 2006-12-14 University Of Virginia Patent Foundation Neurorestoration with R(+) Pramipexole
DE10334188B4 (de) * 2003-07-26 2007-07-05 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung von Depressionen
DE10334187A1 (de) * 2003-07-26 2005-03-03 Schwarz Pharma Ag Substituierte 2-Aminotetraline zur Behandlung von Depressionen
EP1708706A1 (fr) * 2004-01-22 2006-10-11 Boehringer Ingelheim International Gmbh Composition pharmaceutique comprenant un inhibiteur de recaptage du neurotransmetteur monoamine et un agoniste de la dopamine
JP2009504748A (ja) * 2005-08-15 2009-02-05 ユニバーシティ オブ バージニア パテント ファウンデーション R(+)プラミペキソールを用いた神経回復
US8518926B2 (en) 2006-04-10 2013-08-27 Knopp Neurosciences, Inc. Compositions and methods of using (R)-pramipexole
ATE537826T1 (de) 2006-05-16 2012-01-15 Knopp Neurosciences Inc Zusammensetzungen aus r(+)- und s(-)-pramipexol sowie verfahren zu ihrer anwendung
US20080254118A1 (en) * 2007-04-11 2008-10-16 Hans-Werner Wernersbach Process for preparing pramipexole dihydrochloride tablets
US8524695B2 (en) 2006-12-14 2013-09-03 Knopp Neurosciences, Inc. Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same
EP2137171A4 (fr) 2007-03-14 2010-05-19 Knopp Neurosciences Inc Synthèse de benzothiazole diamines substituées et purifiées du point de vue chiral
US20080254117A1 (en) * 2007-04-10 2008-10-16 Noel Cotton Process for preparing pramipexole dihydrochloride tablets
US20110190356A1 (en) * 2008-08-19 2011-08-04 Knopp Neurosciences Inc. Compositions and Methods of Using (R)- Pramipexole
ES2459322T3 (es) 2008-09-05 2014-05-09 Supernus Pharmaceuticals, Inc. Método de tratamiento de trastorno de déficit de atención con hiperactividad (TDAH)
AU2010242971A1 (en) * 2009-04-30 2011-11-24 Supernus Pharmaceuticals, Inc. Method of treatment of depression
US9512096B2 (en) 2011-12-22 2016-12-06 Knopp Biosciences, LLP Synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds
MX356727B (es) 2012-02-08 2018-06-12 Supernus Pharmaceuticals Inc Formulaciones de liberacion modificada de viloxacina.
US9662313B2 (en) 2013-02-28 2017-05-30 Knopp Biosciences Llc Compositions and methods for treating amyotrophic lateral sclerosis in responders
US9468630B2 (en) 2013-07-12 2016-10-18 Knopp Biosciences Llc Compositions and methods for treating conditions related to increased eosinophils
RS61539B1 (sr) 2013-07-12 2021-04-29 Knopp Biosciences Llc Lečenje povišenih nivoa eozinofila i/ili bazofila
CA2921381A1 (fr) 2013-08-13 2015-02-19 Knopp Biosciences Llc Compositions et methodes pour le traitement de l'urticaire chronique
ES2813674T3 (es) 2013-08-13 2021-03-24 Knopp Biosciences Llc Composiciones y métodos para el tratamiento de trastornos de células plasmáticas y trastornos prolinfocíticos de células b
MA51658A (fr) * 2017-04-10 2020-12-02 Chase Therapeutics Corp Association comprenant un antagoniste de nk1 et méthode de traitement de synucléinopathies
EP3645120A4 (fr) * 2017-06-30 2021-03-24 Chase Pharmaceuticals Corporation Compositions d'antagoniste de nk-1 et méthodes destinées à être utilisées dans le traitement de la dépression
CN110028464B (zh) * 2019-04-26 2022-11-18 浙江海洋大学 一种南极真菌次级代谢衍生物BTZ-one及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4536518A (en) * 1979-11-01 1985-08-20 Pfizer Inc. Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine
DE3572485D1 (en) * 1984-12-22 1989-09-28 Thomae Gmbh Dr K Tetrahydro-benzothiazoles, their production and their use as intermediates or drugs
DE3843227A1 (de) * 1988-12-22 1990-07-05 Boehringer Ingelheim Kg Neue verwendung von 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzthiazol
US4962128A (en) * 1989-11-02 1990-10-09 Pfizer Inc. Method of treating anxiety-related disorders using sertraline
DE3937271A1 (de) * 1989-11-09 1991-05-16 Boehringer Ingelheim Kg Transdermale applikation von 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazol
US5248699A (en) * 1992-08-13 1993-09-28 Pfizer Inc. Sertraline polymorph
DE4241013A1 (de) * 1992-12-05 1994-06-09 Boehringer Ingelheim Kg Verwendung von 2-Amino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzothiazol als Arzneimittel mit antidepressiver Wirkung
JP3947582B2 (ja) * 1995-08-15 2007-07-25 中外製薬株式会社 不安神経症治療剤
TR199801929T2 (xx) * 1996-03-29 1998-12-21 Pfizer Inc. Benzil(iden)-laktam t�revleri, bunlar�n 5-HT1A resept�rlerinin (ant)agonistler olarak kullan�mlar� .
ATE282417T1 (de) * 1996-12-02 2004-12-15 Merck Sharp & Dohme Die verwendung von nk-1 rezeptor antagonisten für die behandlung von bewegungsstörungen
CN1293573A (zh) * 1998-01-13 2001-05-02 同步神经元有限责任公司 迟发性运动障碍和其它运动疾病的治疗方法

Also Published As

Publication number Publication date
IL140603A0 (en) 2002-02-10
RS49795B (sr) 2008-06-05
EA003142B1 (ru) 2003-02-27
AR019896A1 (es) 2002-03-20
CZ200177A3 (en) 2001-06-13
KR100557692B1 (ko) 2006-03-07
CN1230168C (zh) 2005-12-07
US6255329B1 (en) 2001-07-03
TR200100146T2 (tr) 2001-07-23
HUP0103922A3 (en) 2002-08-28
BR9911768A (pt) 2001-04-03
NZ509729A (en) 2003-06-30
ID27776A (id) 2001-04-26
CA2336833A1 (fr) 2000-01-20
PL345842A1 (en) 2002-01-14
CA2336833C (fr) 2008-09-23
AU762128B2 (en) 2003-06-19
NO20010064D0 (no) 2001-01-05
AU5030399A (en) 2000-02-01
HK1037976A1 (en) 2002-03-01
SK284923B6 (sk) 2006-02-02
BG105112A (en) 2001-10-31
EP1093369B1 (fr) 2002-11-27
DE19830201A1 (de) 2000-01-13
PT1093369E (pt) 2003-03-31
JP2002520273A (ja) 2002-07-09
TW592698B (en) 2004-06-21
WO2000002542A3 (fr) 2000-06-22
HUP0103922A2 (hu) 2002-03-28
SK112001A3 (en) 2001-10-08
ZA200100090B (en) 2002-04-04
EE200100014A (et) 2002-06-17
DK1093369T3 (da) 2002-12-16
WO2000002542A2 (fr) 2000-01-20
ES2183583T3 (es) 2003-03-16
BG64972B1 (bg) 2006-11-30
KR20010079491A (ko) 2001-08-22
MY117969A (en) 2004-08-30
DE59903556D1 (de) 2003-01-09
EA200100084A1 (ru) 2001-08-27
ATE228365T1 (de) 2002-12-15
CZ294087B6 (cs) 2004-10-13
CN1308533A (zh) 2001-08-15
PL195043B1 (pl) 2007-08-31
EP1093369A2 (fr) 2001-04-25
NO20010064L (no) 2001-03-02
YU401A (sh) 2003-10-31

Similar Documents

Publication Publication Date Title
EE04296B1 (et) Antidepressiivse toimega vahend, mis sisaldab pramipeksooli ja sertraliini
ID28787A (id) 2-fenilbenzimidazol tersubstitusi, pembuatannya dan penggunaannya
ID30393A (id) Senyawa tienopirimidina, pembuatan dan penggunaannya
ID22957A (id) Senyawa dan penggunaannya
MA26866A1 (fr) Agents antibacteriens consistant en 3-aminoquinazoline-2,4-diones
DE69732778D1 (de) Weiche nitrilkautchuk-zusammensetzung
DE69929047D1 (de) Haarbehandlungsmittel
NO20022334L (no) Ny sammensetning og anvendelse
DE69919970D1 (de) Axiallüfter
DE69928874D1 (de) Tonerzusammensetzung, Entwickler und Herstellungsverfahren
FI981614A (fi) Laakerin kunnon evakuointi
ID22889A (id) Komposisi kopolimer etilena dan penggunaannya
DE69822124T2 (de) Axiallüfter
EE200000145A (et) Budesoniidi ja formoterooli uus kasutamine
BR9900685B1 (pt) composição sólida desodorante e utilização cosmética de uma composição sólida.
ID27922A (id) KOMPOSISI FARMASETIKAL DAN PENGGUNAAN DARI ANDROST-5-ENA-3β, 17β-DIOL
DK1112003T3 (da) Ny sammensætning og anvendelse
NO20001847L (no) Ny anvendelse av forbindelser for anti-kløe-aktivitet
IS5951A (is) 5HT1 mótlyf fyrir meðferð gegn þunglyndi
DZ2547A1 (fr) Formes posologiques de sertraline à libération prolongée.
TR199903132A3 (tr) Metalosan bilesiklerinin aktive edici kompozisyonu.
NO20010654L (no) Ny anvendelse av taxoidderivater
EE04087B1 (et) Antimükootiline kompositsioon, selle kasutamine ja valmistamismeetod ning antimükootiline toode
MA26666A1 (fr) Antioxide, composition antiproliferee, y compris carnitine et carotenoide.
PT941081E (pt) Nova utilizacao de creatina

Legal Events

Date Code Title Description
HC1A Change of owner name
KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

MM4A Lapsed by not paying the annual fees

Effective date: 20090702